Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
566 Leser
Artikel bewerten:
(2)

MediXall Group, Inc.: Health Karma Expands Its Partner Program With The Addition Of Leading General Agency, Gem State Financial

BOCA RATON, FL / ACCESSWIRE / January 20, 2022 / MediXall Group Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced today its wholly-owned subsidiary, Health Karma has expanded the Company's Partner Program with the addition of Gem State Financial, a leading Idaho-based General Agency. Gem State Financial selected Health Karma to help clients drive engagement, education and savings through a modern all-in-one consumer healthcare experience.

With over 60 agents, Gem State will now be able to offer virtual health benefits to their client's employees, regardless of if they are full time, part time or 1099. This will allow employees of all industries and pay grades to manage their health through access to a $0 copay virtual primary, urgent, and behavioral care. In addition, Health Karma provides its members significant discounts to prescriptions, dental care, eye care, hearing and medical equipment.

Serving employers in Idaho, Oregon, Utah, & Washington. Gem State Financial Group's mission is to provide clients with the products & services to help meet their situational needs and to develop a long-lasting relationship. Gem State Financial Group offers a wide spectrum of products and services, including medical, dental, vision, and life insurance, as well as final expense policies, disability income insurance, long term care insurance, estate planning, retirement strategies, and financial strategies.

"We are excited to be able to be able to offer another great solution to our product portfolio that will solve our clients needs" said Gem State Financial Group President Scott Leavitt, "Health Karma provides an affordable solution that was missing for part-time & temporary employees as well as a companion to those with a high deductible health insurance plan" Leavitt said.

"By partnering with Gem State Financial Group, Health Karma gains the extensive network and trust that Scott Leavitt and Gem State have built in multiple states and across all sizes of employer groups" said Health Karma CEO Travis Jackson.

For more information on Health Karma, visit their official website: www.healthkarma.org and follow @HealthKarmaApp on Facebook, Instagram, and Twitter. For more information on Gem State Financial Group, visitwww.gemstatefg.com.

About Health Karma, Inc.

Health Karma, a wholly owned subsidiary of MediXall Group, is a data-driven healthcare technology company whose mission is to continually raise the bar of the healthcare experience by empowering people to understand and manage their entire health care journey anywhere, anytime, whether they have insurance or not. For more information, please visit www.healthkarma.org.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the company's ability to raise additional capital, execute its business plan and strategy, sustain, or increase gross margins, achieve profitability, and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise forward-looking statements, whether from new information, future events or otherwise.

Contact: Investor Relations, (954) 653-8216

Media Contact: Karla Hernandez, karlahernandez.transmediagroup@gmail.com, 561-750-9800

SOURCE: MediXall Group, Inc.



View source version on accesswire.com:
https://www.accesswire.com/684754/Health-Karma-Expands-Its-Partner-Program-With-The-Addition-Of-Leading-General-Agency-Gem-State-Financial

© 2022 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.